A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04948645

Recruitment Status : Active, not recruiting

First Posted : July 2, 2021

Last Update Posted : January 25, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

AbbVie

Information provided by (Responsible Party):

Calico Life Sciences LLC

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	January 12, 2023
Estimated Study Completion Date :	December 2025

To Top